Abstract
Background
One upside of cervical esophageal carcinoma is that radical surgery can be performed by laryngectomy, even for tumors with tracheal invasion. However, this approach drastically reduces the quality of life, such as by losing the vocal function. Cervical esophageal carcinoma is rare, and no comprehensive reports have described the current state of surgery. Using a Japanese nationwide web-based database, we analyzed the surgical outcomes of cervical esophageal carcinoma to evaluate the impact of larynx-preserving surgery.
Methods
Based on the Japan National Clinical Database, 215 surgically treated cases of cervical esophageal carcinoma between January 1, 2018, and December 31, 2019, were enrolled. Clinical outcomes were compared between the larynx-preserved group and the laryngectomy group.
Results
Ninety-four (43.7%) patients underwent larynx-preserving surgery. A total of 177 (82.3%) patients underwent free jejunum reconstruction. More T4b patients and more patients who underwent preoperative radiotherapy were in the laryngectomy group. There were no significant differences in the frequency and the severity of morbidities between the two groups. However, in the laryngectomy group, in-hospital death within 30 days after surgery was observed in 1 patient, and the postoperative hospital stay was significantly longer (P = 0.030). In the larynx-preserved group, recurrent nerve paralysis was observed in 24.5%. Re-operation (35.3%, P = 0.016), re-intubation (17.6%, P = 0.019) and tracheal necrosis (17.6%, P = 0.028) were significantly more frequent in patients who underwent pharyngolaryngectomy with total esophagectomy and gastric tube reconstruction than in others.
Conclusion
Larynx-preserving surgery was therefore considered to be feasible because it was equivalent to laryngectomy regarding the short-term surgical outcomes.
Similar content being viewed by others
References
Kitagawa Y, Uno T, Oyama T, et al. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2. Esophagus. 2019;16:25–43.
Kuwano H, Nishimura Y, Oyama T, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan esophageal society. Esophagus. 2015;12:1–30.
Watanabe M, Toh Y, Ishihara R, et al. Comprehensive registry of esophageal cancer in Japan, 2014. Esophagus. 2022;19:1–26.
Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery. Thoracic and cardiovascular surgeries in Japan during Annual report by the Japanese association for thoracic surgery. Gen Thorac Cardiovasc Surg. 2017;2020(68):414–49.
Kato H, Kitagawa Y, Kuwano H, et al. Neo-adjuvant therapy or definitive chemoradiotherapy can improve laryngeal preservation rates in patients with cervical esophageal cancer. Jpn Nationwide Surv Esophagus. 2016;13:276–82.
Takebayashi K, Tsubosa Y, Matsuda S, et al. Comparison of curative surgery and definitive chemoradiotherapy as initial treatment for patients with cervical esophageal cancer. Dis Esophagus. 2017;30:1–5.
Gotoh M, Miyata H, Hashimoto H, et al. National clinical database feedback implementation for quality improvement of cancer treatment in Japan: from good to great through transparency. Surg Today. 2016;46:38–47.
Hasegawa H, Takahashi A, Kakeji Y, et al. Surgical outcomes of gastroenterological surgery in Japan: report of the national clinical database 2011–2017. Ann Gastroenterol Surg. 2019;3:426–50.
International Union against Cancer, SobinGospodarowiczWittekind LHMKC. TNM classification of malignant tumours. 7th ed. Hoboken: Wiley-Blackwell; 2010.
Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.
Nakajima Y, Kawada K, Tokairin Y, et al. “Larynx-preserving surgery” for cervical esophageal carcinoma can preserve the vocal function and improve the clinical outcome. Esophagus. 2017;14:76–83.
Watanabe A, Taniguchi M, Kimura Y, et al. Larynx-preserving hybrid surgery with endoscopic laryngopharyngeal surgery and open surgery for cervical esophageal cancer invading pharynx. Dis Esophagus. 2020;33:doaa020.
Nozaki I, Kato K, Igaki H, et al. Evaluation of safety profile of thoracoscopic esophagectomy for T1bN0M0 cancer using data from JCOG0502: a prospective multicenter study. Surg Endosc. 2015;29:3519–26.
Takeuchi H, Miyata H, Ozawa S, et al. Comparison of short-term outcomes between open and minimally invasive esophagectomy for esophageal cancer using a nationwide database in Japan. Ann Surg Oncol. 2017;24:1821–7.
Motoyama S, Yamamoto H, Miyata H, et al. Impact of certification status of the institute and surgeon on short-term outcomes after surgery for thoracic esophageal cancer: evaluation using data on 16,752 patients from the National Clinical Database in Japan. Esophagus. 2020;17:41–9.
Shiozaki H, Tsu**aka T, Inoue M, et al. Larynx preservation in surgical treatment of cervical esophageal cancer—combined procedure of laryngeal suspension and cricopharyngeal myotomy. Dis Esophagus. 2000;13:213–8.
Ott K, Lordick F, Molls M, et al. Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical oesophagus. Br J Surg. 2009;96:258–66.
Kadota H, Sakuraba M, Kimata Y, et al. Larynx-preserving esophagectomy and jejunal transfer for cervical esophageal carcinoma. Laryngoscope. 2009;119:1274–80.
Miyata H, Yamasaki M, Takahashi T, et al. Larynx-preserving limited resection and free jejunal graft for carcinoma of the cervical esophagus. World J Surg. 2013;37:551–7.
Wong IYH, Zhang RQ, Tsang RKY, et al. Improving outcome of superior mediastinal lymph node dissection during esophagectomy: a novel approach combining continuous and intermittent recurrent laryngeal nerve monitoring. Ann Surg. 2021;274:736–42.
Wang X, Guo H, Hu Q, et al. Efficacy of intraoperative recurrent laryngeal nerve monitoring during thoracoscopic esophagectomy for esophageal cancer: a systematic review and meta-analysis. Front Surg. 2021;8: 773579.
Fujiki M, Miyamoto S, Sakuraba M, et al. Risk factors for tracheal necrosis after total pharyngolaryngectomy. Head Neck. 2015;37:1207–10.
Kamiyama R, Mitani H, Yonekawa H, et al. A clinical study of pharyngolaryngectomy with total esophagectomy: postoperative complications, countermeasures, and prognoses. Otolaryngol Head Neck Surg. 2015;153:392–9.
Niwa Y, Koike M, Fujimoto Y, et al. Salvage pharyngolaryngectomy with total esophagectomy following definitive chemoradiotherapy. Dis Esophagus. 2016;29:598–602.
Booka E, Tsubosa Y, Niihara M, et al. Risk factors for complications after pharyngolaryngectomy with total esophagectomy. Esophagus. 2016;13:317–22.
Acknowledgements
The authors sincerely thank all participants in the NCD project for their great efforts in data registration. We thank Shinya Hirakawa, PhD, for his efforts in data management as a sub-analyzer. We also thank Takeshi Naito, MD, PhD and Kinji Kamiya, MD, PhD, for giving appropriate advice as a supervisor, and we also thank the working members of the database committee in the Japanese Society of Gastroenterological Surgery and the Japan Esophageal Society. The authors wish to acknowledge Mr. Keita Shimoakasho, the Japanese Society of Gastroenterological Surgery and Ms. Hitomi Okamoto, Ms. Natsumi Yamamoto and Mr. Nariyoshi Butsuda, National Clinical Database, Japan, for their valuable assistance regarding administration and database information.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Statement
The study protocol was approved by the Japan Esophageal Society, the Japanese Society of Gastroenterological Surgery, and the Institutional Review Board of Edogawa Hospital (Approval Number 2020–19).
Conflict of interest
Author HM are affiliated of a social collaboration department supported by Grants from National Clinical Database, Johnson & Johnson KK, and Nipro Co. Author YK are supported by grants from Takeda Pharmaceutical Co., Ltd., CHUGAI PHARMACEUTICAL CO., LTD., TAIHO PHARMACEUTICAL CO., LTD, Yakult Honsha Co. Ltd., ASAHI KASEI PHARMA CORPORATION, Otsuka Pharmaceutical Co., Ltd., ONO PHARMACEUTICAL CO., LTD., TSUMURA & CO., Kyouwa Hakkou Kirin Co., Ltd., DAINIPPON SUMITOMO PHARMA Co., Ltd., EA Pharma Co., Ltd., Astellas Pharma Inc., Toyama Chemical Co., Ltd, MEDICON INC., KAKEN PHARMACEUTICAL CO. LTD., Eisai Co., Ltd., Otsuka Pharmaceutical Factory Inc., TEIJIN PHARMA LIMITED., NIHON PHARMACEUTICAL CO., LTD. and Nippon Covidien Inc.. Author YK also received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from CHUGAI PHARMACEUTICAL CO., LTD., TAIHO PHARMACEUTICAL CO., LTD, ASAHI KASEI PHARMA CORPORATION, Otsuka Pharmaceutical Factory Inc., SHIONOGI & CO., LTD., Nippon Covidien Inc., Ethicon, Inc., ONO PHARMACEUTICAL CO., LTD., Olympus Corporation, Bristol-Myers Squibb KK, AstraZeneca KK, MSD KK, Smith & Nephew KK and KAKEN PHARMACEUTICAL CO., LTD.. Other authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Nakajima, Y., Tachimori, H., Miyawaki, Y. et al. A survey of the clinical outcomes of cervical esophageal carcinoma surgery focusing on the presence or absence of laryngectomy using the National Clinical Database in Japan. Esophagus 19, 569–575 (2022). https://doi.org/10.1007/s10388-022-00944-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10388-022-00944-3